- Report
- March 2024
- 187 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- March 2024
- 193 Pages
Global
From €3241EUR$3,374USD£2,790GBP
€3601EUR$3,749USD£3,100GBP
- Report
- December 2023
- 180 Pages
Global
From €5715EUR$5,950USD£4,920GBP
- Report
- March 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- November 2023
- 150 Pages
Global
From €4658EUR$4,850USD£4,010GBP
- Report
- April 2024
- 137 Pages
Global
From €3745EUR$3,899USD£3,224GBP
- Report
- May 2024
- 299 Pages
Global
From €5235EUR$5,450USD£4,507GBP
- Report
- May 2024
- 326 Pages
Global
From €5235EUR$5,450USD£4,507GBP
- Report
- April 2024
- 137 Pages
Global
From €3745EUR$3,899USD£3,224GBP
- Report
- April 2024
- 146 Pages
Global
From €3745EUR$3,899USD£3,224GBP
- Report
- November 2023
- 143 Pages
Global
From €2400EUR$2,499USD£2,066GBP
- Report
- October 2023
- 170 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- November 2023
- 180 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €2401EUR$2,500USD£2,067GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1441EUR$1,500USD£1,240GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,240GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,240GBP
- Report
- November 2023
- 182 Pages
Global
From €4706EUR$4,900USD£4,052GBP
The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more